Litigation Details for Ravgen, Inc. v. Ariosa Diagnostics, Inc. (D. Del. 2020)
✉ Email this page to a colleague
Ravgen, Inc. v. Ariosa Diagnostics, Inc. (D. Del. 2020)
Docket | ⤷ Try a Trial | Date Filed | 2020-12-02 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | Plaintiff | Referred To | Jennifer L. Hall |
Patents | 7,727,720 | ||
Link to Docket | External link to docket |
Biologic Drugs cited in Ravgen, Inc. v. Ariosa Diagnostics, Inc.
The biologic drugs covered by the patent cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Ravgen, Inc. v. Ariosa Diagnostics, Inc. (D. Del. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2020-12-02 | 1 | Complaint | United States Patent Nos. 7,727,720 (the “’720 Patent”) and 7,332,277 (the “’277 Patent”) (collectively…number of patents and patent applications that are related to subject matter similar to the Patents-in-Suit…Ravgen’s ’277 Patent or the application that matured into Ravgen’s ’277 Patent (U.S. Patent Application…Ravgen’s ’277 Patent or the application that matured into Ravgen’s ’277 Patent (U.S. Patent Application…Ravgen’s ’720 Patent or the application that matured into Ravgen’s ’720 Patent (U.S. Patent Application | External link to document |
2021-02-18 | 20 | Complaint - Amended | United States Patent Nos. 7,727,720 (the “’720 Patent”) and 7,332,277 (the “’277 Patent”) (collectively…number of patents and patent applications that are related to subject matter similar to the Patents-in-Suit…Ravgen’s ’277 Patent or the application that matured into Ravgen’s ’277 Patent (U.S. Patent Application…Ravgen’s ’277 Patent or the application that matured into Ravgen’s ’277 Patent (U.S. Patent Application…Ravgen’s ’720 Patent or the application that matured into Ravgen’s ’720 Patent (U.S. Patent Application | External link to document |
2023-07-10 | 205 | Report and Recommendations | United States Patent Nos. 7,727,720 (the “ʼ720 patent”), and 7,332,277 (the “ʼ277 patent”). The Court …inhibits] cell lysis” (ʼ277 patent, claims 8, 55, and 81; ʼ720 patent, claim 1) 2 “cell … by the patent, so that interested members of the public, e.g., competitors of the patent owner, can…at the time the patent was filed, and it should be considered in view of the patent’s specification… and 81 of the ʼ277 patent and claim 1 of the ʼ720 patent. Each of those | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |